Health Sciences Clinical Professor
Associate Fellowship Program Director
To see if Shubha Ananthakrishnan is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).
4860 Y St.
Sacramento, CA 95817
UC Davis Medical Group - Elk Grove Specialty Care
9390 Bighorn Blvd.
Elk Grove, CA 95758
I welcome you to the kidney clinic at UC Davis! I look forward to meeting you and working with you towards your goals of better kidney health. I wish to get to know you as a person first, thoroughly assess your health issues, make a plan together with you, be your health advocate and continue to guide you along this journey.
Dr. Shubha Ananthakrishnan is a board certified adult nephrologist offering care for adults with kidney disease due to diabetes, hypertension, glomerular disease etc. She also cares for patients on dialysis and patients after kidney transplantation. She has special clinical interest in home based dialysis therapies and patient education on various aspects of kidney disease management.
Dr. Shubha has special interest in medical education. She teaches students, residents and fellows at various settings. She is the co-discipline lead for Nephrology and an academic coach, at the UC Davis School of Medicine. She also serves as the Director Curricular Development for the Nephrology Fellowship Program.
M.B.B.S., Kilpauk Medical College, Chennai, India 1997
Internal Medicine, Kaiser Foundation Hospital, Oakland CA 2000-2001
Internal Medicine, Kaiser Foundation Hospital, Oakland CA 2001-2003
Chief Resident, Kaiser Foundation Hospital, Oakland CA 2003-2004
Nephrology, Kaiser Foundation Hospital, Los Angeles CA 2004-2006
Home Dialysis, UHN, University of Toronto, Toronto, Ontario, Canada 2010
Sacramento Magazine Top Doctors, 2018, 2019, 2020, 2021
Inspirational Faculty Educator nominee, UC Davis School of Medicine, 2020, 2021
Kaiser Award for Excellence in Teaching-Clinical Sciences, 2021
Outstanding Subspeciality Faculty, Dept of Internal Medicine, UC Davis, 2018, 2021
Dean's Award for Excellence - Inspirational Faculty Educator, 2018
Yuen NK, Ananthakrishnan S, Campbell MJ. Hyperparathyroidism of Renal Disease. Perm J. 2016 Summer;20(3):15-127. doi:10.7812/TPP/15-127. Epub 2016 Jul 22. PMID:27479950.
Ananthakrishnan S, Depner TA. Dose Targeting Metrics in Conventional and Intensive Maintenance Dialysis. Semin Dial. 2016 Nov;29(6):471-475. doi:10.1111/sdi.12526. Epub 2016 Sep 4. PMID:27592623.
Ananthakrishnan S, Kaysen GA. Treatment of Hyperlipidemia Changes With Level of Kidney Function-Rationale. Adv Chronic Kidney Dis. 2016 Jul;23(4):247-54. doi:10.1053/j.ackd.2015.12.004. PMID:27324678.
Ananthakrishnan S. ACP Journal Club. Trimethoprim-sulfamethoxazole was linked to sudden death in older patients using spironolactone. Ann Intern Med. 2015 Jun 16;162(12):JC13. doi:10.7326/ACPJC-2015-162-12-013. PMID:26075778.
Wung W, Ananthakrishnan S, Jonas BA. Proteinuria, Hypoalbuminemia, and Chronic Lymphocytic Leukemia: An Unusual Trio. J Investig Med High Impact Case Rep. 2018 Mar 14;6:2324709618764207. doi:10.1177/2324709618764207. PMID:29568782.
Ananthakrishnan S, Sekercioglu N, Elias RM, Kim J, Oreopoulos D, Chu M, Bargman JM. Peritoneal dialysis outcomes in a modern cohort of overweight patients. Int Urol Nephrol. 2014 Jan;46(1):183-9. doi:10.1007/s11255-013-0472-5. Epub 2013 Jun 23. PMID:23793809.
Kumar VA, Ananthakrishnan S, Rasgon SA, Yan E, Burchette R, Dewar K. Comparing cardiac surgery in peritoneal dialysis and hemodialysis patients: perioperative outcomes and two-year survival. Perit Dial Int. 2012 Mar-Apr;32(2):137-41. doi:10.3747/pdi.2010.00263. Epub 2011 Sep 30. PMID:21965618.
Ananthakrishnan S, Klatsky AL, Udaltsova N, Iribarren C, Guidry U. Analysis of late risk of systemic blood pressures <120/80 mm Hg. Am J Cardiol. 2004 Dec 15;94(12):1575-6. doi:10.1016/j.amjcard.2004.08.045. PMID:15589023.